Free Trial

Anuradha Muralidharan Sells 14,961 Shares of Expensify (NASDAQ:EXFY) Stock

Expensify logo with Business Services background

Key Points

  • Anuradha Muralidharan, COO of Expensify, sold 14,961 shares on September 19 at an average price of $1.94, reducing their position by 20.37% to 58,475 shares valued at $113,441.50.
  • Expensify stock traded down 2.0% to $1.93, with a market capitalization of $155.46 million and a 52-week price range between $1.60 and $4.13.
  • Wall Street analysts generally maintain a positive outlook on Expensify, with ratings varying from "buy" to "hold" and a consensus target price of $4.00.
  • Five stocks to consider instead of Expensify.

Expensify, Inc. (NASDAQ:EXFY - Get Free Report) COO Anuradha Muralidharan sold 14,961 shares of the company's stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $1.94, for a total transaction of $29,024.34. Following the completion of the sale, the chief operating officer owned 58,475 shares in the company, valued at $113,441.50. This represents a 20.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Anuradha Muralidharan also recently made the following trade(s):

  • On Thursday, September 18th, Anuradha Muralidharan sold 2,486 shares of Expensify stock. The stock was sold at an average price of $1.95, for a total transaction of $4,847.70.
  • On Tuesday, September 16th, Anuradha Muralidharan sold 409 shares of Expensify stock. The stock was sold at an average price of $1.90, for a total transaction of $777.10.
  • On Wednesday, August 27th, Anuradha Muralidharan sold 25,245 shares of Expensify stock. The stock was sold at an average price of $1.94, for a total transaction of $48,975.30.
  • On Wednesday, August 20th, Anuradha Muralidharan sold 1,558 shares of Expensify stock. The stock was sold at an average price of $1.72, for a total transaction of $2,679.76.

Expensify Trading Down 2.0%

Shares of EXFY stock traded down $0.04 during trading hours on Wednesday, hitting $1.93. 821,918 shares of the company were exchanged, compared to its average volume of 553,478. The firm has a fifty day simple moving average of $1.96 and a 200 day simple moving average of $2.42. Expensify, Inc. has a 52-week low of $1.60 and a 52-week high of $4.13. The stock has a market capitalization of $155.46 million, a price-to-earnings ratio of -12.06 and a beta of 1.72.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Expensify from a "hold" rating to a "buy" rating in a research note on Tuesday, August 19th. BMO Capital Markets reduced their price objective on shares of Expensify from $3.00 to $2.50 and set a "market perform" rating for the company in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, Expensify has an average rating of "Moderate Buy" and a consensus target price of $4.00.

Read Our Latest Stock Analysis on Expensify

Institutional Trading of Expensify

Several hedge funds have recently added to or reduced their stakes in the business. Acadian Asset Management LLC raised its stake in shares of Expensify by 64.8% during the first quarter. Acadian Asset Management LLC now owns 1,418,512 shares of the company's stock valued at $4,308,000 after acquiring an additional 557,533 shares during the last quarter. Northern Trust Corp raised its stake in shares of Expensify by 15.8% during the fourth quarter. Northern Trust Corp now owns 107,305 shares of the company's stock valued at $359,000 after acquiring an additional 14,676 shares during the last quarter. Vontobel Holding Ltd. bought a new position in shares of Expensify during the first quarter valued at about $159,000. Bank of America Corp DE raised its stake in shares of Expensify by 42.4% during the fourth quarter. Bank of America Corp DE now owns 215,251 shares of the company's stock valued at $721,000 after acquiring an additional 64,088 shares during the last quarter. Finally, Palogic Value Management L.P. raised its stake in shares of Expensify by 31.5% during the first quarter. Palogic Value Management L.P. now owns 724,485 shares of the company's stock valued at $2,202,000 after acquiring an additional 173,679 shares during the last quarter. 68.42% of the stock is owned by institutional investors.

About Expensify

(Get Free Report)

Expensify, Inc provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel.

Featured Articles

Insider Buying and Selling by Quarter for Expensify (NASDAQ:EXFY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Expensify Right Now?

Before you consider Expensify, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Expensify wasn't on the list.

While Expensify currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.